Journal content

DECISIO Reveals New Leadership and Closes Series B Funding Round |

HOUSTON, March 28, 2022 /PRNewswire/ — DECISIO has appointed Major General Elder Granger, MD (retired) to the company’s board of directors. Dr. Granger is currently President and CEO of The 5Ps, LLC, a healthcare, education and leadership consulting organization. Prior to his retirement from the U.S. Army, Dr. Granger served as Deputy Director of TRICARE Management Activity, a Department of Defense (DoD) field activity responsible for operating the military health care system as a system fully integrated health within the DoD. He was responsible for overseeing and administering TRICARE programs, providing oversight of accessible, high-quality health care for 9.2 million beneficiaries worldwide.

“Having Dr. Granger join our Board of Directors brings enormous value and validation to the future of our business,” said Dr. Granger. John Holcomb, Co-CEO and Co-founder of DECISIO. “His expertise and leadership in the healthcare industry is a welcome addition to our esteemed Board group.”

In addition to his accomplished military career, Dr. Granger is board certified by the American Board of Internal Medicine and the Board of Hematology and Oncology. He is an executive physician certified by the Medical Management Certification Board of the American College of Healthcare Executives and certified in medical quality by the American Board of Medical Quality. Dr. Granger also serves on the board of directors of Cerner Corporation, Cigna Corporation and DLH Holdings Corporation and is a member of the board of directors of Rosalind Franklin University.

DECISIO also announces the official closure of its $180.5 million Series B funding in February 2022bringing the total funds raised to date to $31.5 million. Funds from this round will be used for marketing, ongoing product development and growing operations.

On DECISIO® DECISIO is a Houstondigital health company with a customizable clinical decision support platform designed to aggregate and prioritize data in real time, from any device, and present it visually in one place. The flagship product, InsightIQ, uses continuous intelligent bedside monitoring that enables clinical teams to effectively identify at-risk patients and adhere to established clinical guidelines. InsightIQ improves patient outcomes and throughput, optimizes workflow, increases collaboration, reducing length of stay and “click” fatigue. Our solutions, including actionable analytics, that can be scaled across an entire healthcare system or used in a single area of ​​care. For more information, visit www.decisiohealth.com.

[email protected]

Show original content to download multimedia:https://www.prnewswire.com/news-releases/decisio-reveals-new-leadership-and-closes-series-b-funding-round-301511118.html

SOURCE DECISION